Bonjour Europe

NICE ASSESSMENT OUTCOMES

Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS

Drug approvals in Europe | EMA drug approvals in 2022 | European Commission News | iPharmaCenter

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

COVID19 drug updates | FDA EMA approved COVID19 drugs

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

HIV News and media blogs | Viiv's Apretude approved in the US for HIV prevention

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

NHS England News | NHS to offer Tagrisso for lung cancer patients

United Kingdom COVID19 News | Has Britain reached herd immunity?

European Commission approved Benlysta for active lupus nephritis

France COVID-19 Updates | COVID-19 News in Europe

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

CHMP Opinions | EMA drug approvals

Expected best selling pharmaceutical products (drugs) in 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients

Kite’s CAR-Tcell therapy received approval in Europe for relapsed or refractory mantle cell lymphoma

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

HAS says Gilead's Veklury 'does not improve benefit' for COVID19 patients; EMA to review safety

Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA

ESMO 2020

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Gene therapy developer AveXis renamed as Novartis Gene Therapies

European Society of Cardiology Congress 2020

European Commission approved GSK’s Blenrep for relapsed and refractory multiple myeloma

JULY 2020 CHMP POSITIVE OPINION

European Commission approved Lynparza for metastatic pancreatic cancer

Gilead’s Veklury received conditional marketing authorization from the European Commission

European Commission approved Janssen's Ebola vaccine

GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial

Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit

#EULAR2020

Sanofi’s Sarclisa approved in Europe for relapsed and refractory multiple myeloma

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

European Commission approved Zolgensma, activates “Day one” access program

HAS gave favorable opinion for reimbursing Darzalex for treating multiple myeloma naïve patients

EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

Novo Nordisk’s Rybelsus approved by European Union

NICE recommendation to manage symptoms of COVID-19

EMA approved GSK’s Trelegy Ellipta for asthma

EMA approved Mayzent (siponimod) for secondary progressive multiple sclerosis

European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA

CHMP gave positive opinions for Beovu and Recarbrio